Filter
2645
Filtered Results: 2645
Text search:
regulatory
control
Featured
Recommendations
233
New Publications
716
Language
Document type
No document type
1288
Studies & Reports
468
Guidelines
460
Manuals
164
Strategic & Response Plan
144
Fact sheets
62
Situation Updates
23
Training Material
20
Resource Platforms
6
Brochures
5
Infographics
3
Online Courses
2
Countries / Regions
Global
109
Kenya
100
India
89
Ethiopia
60
Nigeria
54
Latin America and the Carribbean
49
Western and Central Europe
49
Uganda
46
Sierra Leone
45
South Africa
45
Liberia
43
Ghana
41
Africa
41
Zambia
36
Nepal
33
Tanzania
33
Bangladesh
31
Rwanda
28
Myanmar / Burma
28
Ukraine
27
Malawi
25
Namibia
24
South–East Asia Region
24
East and Southern Africa
23
West and Central Africa
23
Philippines
21
Syria
21
Eastern Europe
20
Lesotho
19
Middle East and North Africa
18
Paraguay
18
Guinea
13
Zimbabwe
13
Cambodia
12
Asia
12
Congo, Democratic Republic of
11
Mozambique
11
Botswana
11
El Salvador
11
Eastern Europe and Central Asia
11
Argentina
10
Eswatini/ Swaziland
10
South Sudan
9
Indonesia
9
Western Pacific Region
9
Russia
9
Senegal
8
Pakistan
7
Brazil
7
USA
6
Cameroon
6
Bolivia
6
Chile
6
Yemen
6
Burkina Faso
5
Haiti
5
Sudan
5
Colombia
5
Venezuela
5
Moldova
5
Spain
5
Somalia
4
Jordan
4
Germany
4
Thailand
4
Ecuador
4
Angola
4
Albania
4
Tajikistan
4
Georgia
4
Guinea-Bissau
3
Afghanistan
3
Chad
3
Benin
3
Peru
3
Laos
3
North America
3
United Kingdom
3
Mali
2
Saudi Arabia
2
Iraq
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
North Macedonia
2
Honduras
2
Guatemala
2
Madagascar
2
Bhutan
2
Timor Leste/ East Timor
2
Iran
2
Kazakhstan
2
Vietnam
2
Turkmenistan
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Turkey
1
Egypt
1
Gambia
1
Mauritania
1
Greece
1
Libya
1
Sri Lanka
1
Fiji
1
Palestine
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1003
Clinical Guidelines
197
Public Health
183
Key Resources
122
Women & Child Health
92
Pharmacy & Technologies
66
Capacity Building
25
Toolboxes
COVID-19
274
AMR
176
HIV
164
TB
137
Pharmacy
120
Mental Health
118
Planetary Health
110
Rapid Response
100
Caregiver
90
NCDs
58
Ebola
54
NTDs
49
Global Health Education
45
Conflict
42
Specific Hazards
35
Disability
31
Refugee
28
Health Financing Toolbox
26
Natural Hazards
22
Zika
19
Polio
17
Cholera
9
Social Ethics
9
The WHO European Office for the Prevention and Control of Noncommunicable Diseases organized an expert meeting on monitoring of digital marketing of unhealthy products to children and adolescents in June 2018. Based on that meeting, this report aims to provide a tool to support Member States in moni...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in ...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Health care waste management (HCWM) and infection prevention and control (IPC) represent serious concerns for HIV programs. Improperly handled infectious health care waste poses risks to health workers, their clients, the community, and the environment. Improper injection practices can lead to new H...
THE REPUBLIC OF BOTSWANA | MINISTRY OF HEALTH | DEPARTMENT OF PUBLIC HEALTH | NATIONAL MALARIA CONTROL PROGRAMME
An Act to provide for the efficient and comprehensive regulation and control of food, drugs, medical devices, cosmetics, herbal drugs and poisons and to repeal the Food
(Control of Quality) Act, 1978, the Pharmaceuticals and Poisons Act, 1978 and to provide for related matters.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to generate comparable data for their registering and labell...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
Globally, the cancer burden is rising, exerting significant strain on
populations and health systems at all levels of income. There are
concerted efforts towards enhancing access to comprehensive
cancer prevention and control initiatives.
